$77.6
Live
0.4%
Downside
Day's Volatility :2.05%
Upside
1.66%
33.52%
Downside
52 Weeks Volatility :40.1%
Upside
9.9%
Period | National Health Investors Inc. | Sector (Real Estate) | Index (Russel 2000) |
---|---|---|---|
3 Months | 4.84% | 3.1% | 0.0% |
6 Months | 17.15% | 13.5% | 0.0% |
1 Year | 45.54% | 20.5% | 0.0% |
3 Years | 36.14% | -10.1% | -26.7% |
Market Capitalization | 3.6B |
Book Value | $33.73 |
Dividend Share | 3.6 |
Dividend Yield | 4.49% |
Earnings Per Share (EPS) | 2.84 |
PE Ratio | 27.54 |
PEG Ratio | 1.99 |
Wall Street Target Price | 85.86 |
Profit Margin | 38.44% |
Operating Margin TTM | 62.55% |
Return On Assets TTM | 4.7% |
Return On Equity TTM | 9.93% |
Revenue TTM | 329.8M |
Revenue Per Share TTM | 7.6 |
Quarterly Revenue Growth YOY | -11.700000000000001% |
Gross Profit TTM | 269.0M |
EBITDA | 256.2M |
Diluted Eps TTM | 2.84 |
Quarterly Earnings Growth YOY | -0.14 |
EPS Estimate Current Year | 2.98 |
EPS Estimate Next Year | 3.14 |
EPS Estimate Current Quarter | 0.73 |
EPS Estimate Next Quarter | 0.76 |
What analysts predicted
Upside of 10.64%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 294.6M | ↑ 5.72% |
Net Income | 154.3M | ↓ 3.16% |
Net Profit Margin | 52.39% | ↓ 4.8% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 318.1M | ↑ 7.97% |
Net Income | 104.2M | ↓ 32.51% |
Net Profit Margin | 32.75% | ↓ 19.64% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 332.8M | ↑ 4.63% |
Net Income | 135.4M | ↑ 29.97% |
Net Profit Margin | 40.67% | ↑ 7.92% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 298.7M | ↓ 10.24% |
Net Income | 62.2M | ↓ 54.06% |
Net Profit Margin | 20.82% | ↓ 19.85% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 278.2M | ↓ 6.87% |
Net Income | 23.1M | ↓ 62.92% |
Net Profit Margin | 8.29% | ↓ 12.53% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 319.8M | ↑ 14.97% |
Net Income | 135.7M | ↑ 488.27% |
Net Profit Margin | 42.41% | ↑ 34.12% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 77.9M | ↓ 5.48% |
Net Income | 39.8M | ↑ 411.43% |
Net Profit Margin | 51.08% | ↑ 41.64% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 80.1M | ↑ 2.86% |
Net Income | 29.3M | ↓ 26.23% |
Net Profit Margin | 36.63% | ↓ 14.45% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 79.5M | ↓ 0.8% |
Net Income | 32.0M | ↑ 9.2% |
Net Profit Margin | 40.33% | ↑ 3.7% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 82.2M | ↑ 3.49% |
Net Income | 30.9M | ↓ 3.43% |
Net Profit Margin | 37.63% | ↓ 2.7% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 85.7M | ↑ 4.2% |
Net Income | 35.3M | ↑ 13.92% |
Net Profit Margin | 41.14% | ↑ 3.51% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 69.2M | ↓ 19.28% |
Net Income | 28.5M | ↓ 19.05% |
Net Profit Margin | 41.26% | ↑ 0.12% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 2.8B | ↑ 8.04% |
Total Liabilities | 1.4B | ↑ 11.21% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 3.0B | ↑ 10.6% |
Total Liabilities | 1.5B | ↑ 13.46% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 3.1B | ↑ 2.57% |
Total Liabilities | 1.6B | ↑ 3.47% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.8B | ↓ 9.02% |
Total Liabilities | 1.3B | ↓ 17.25% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 2.5B | ↓ 11.68% |
Total Liabilities | 1.2B | ↓ 7.9% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 2.5B | ↓ 0.76% |
Total Liabilities | 1.2B | ↓ 0.25% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.5B | ↓ 1.37% |
Total Liabilities | 1.2B | ↓ 2.93% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.5B | ↑ 0.02% |
Total Liabilities | 1.2B | ↑ 0.84% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.5B | ↓ 0.42% |
Total Liabilities | 1.2B | ↓ 0.31% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 2.5B | ↓ 0.42% |
Total Liabilities | 1.2B | ↓ 0.32% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 2.5B | ↓ 0.05% |
Total Liabilities | 1.2B | ↑ 0.24% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 2.5B | ↓ 0.68% |
Total Liabilities | 1.2B | ↓ 0.06% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 207.9M | ↑ 5.34% |
Investing Cash Flow | -250.3M | ↑ 52.76% |
Financing Cash Flow | 44.3M | ↓ 226.26% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 241.0M | ↑ 15.92% |
Investing Cash Flow | -342.5M | ↑ 36.85% |
Financing Cash Flow | 107.3M | ↑ 142.49% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 232.1M | ↓ 3.66% |
Investing Cash Flow | -89.7M | ↓ 73.81% |
Financing Cash Flow | -111.8M | ↓ 204.14% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 210.9M | ↓ 9.17% |
Investing Cash Flow | 185.3M | ↓ 306.52% |
Financing Cash Flow | -403.0M | ↑ 260.58% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 185.3M | ↓ 12.1% |
Investing Cash Flow | 197.9M | ↑ 6.84% |
Financing Cash Flow | -401.3M | ↓ 0.43% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 50.5M | ↑ 62.64% |
Investing Cash Flow | 33.5M | ↓ 221.73% |
Financing Cash Flow | -80.3M | ↑ 743.32% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 49.7M | ↓ 1.57% |
Investing Cash Flow | -19.9M | ↓ 159.54% |
Financing Cash Flow | -30.5M | ↓ 61.95% |
Sell
Neutral
Buy
National Health Investors Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
National Health Investors Inc. | 2.34% | 17.15% | 45.54% | 36.14% | -2.02% |
Healthpeak Properties, Inc. | -1.05% | 9.23% | 83.79% | 16.9% | 17.6% |
Ventas, Inc. | 0.81% | 34.38% | 44.8% | 18.54% | 10.06% |
Welltower Inc. | 5.76% | 36.56% | 55.22% | 60.22% | 61.44% |
Omega Healthcare Investors Inc. | 0.28% | 29.81% | 26.69% | 40.41% | -4.05% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
National Health Investors Inc. | 27.54 | 27.54 | 1.99 | 2.98 | 0.1 | 0.05 | 0.04 | 33.73 |
Healthpeak Properties, Inc. | 45.4 | 45.4 | 4.16 | 0.36 | 0.04 | 0.02 | 0.05 | 12.24 |
Ventas, Inc. | 2223.5 | NA | 2.28 | -0.01 | -0.01 | 0.02 | 0.03 | 23.28 |
Welltower Inc. | 86.6 | 86.6 | 2.34 | 1.52 | 0.03 | 0.02 | 0.02 | 49.05 |
Omega Healthcare Investors Inc. | 30.13 | 30.13 | 1.13 | 1.47 | 0.09 | 0.04 | 0.06 | 15.69 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
National Health Investors Inc. | Buy | $3.6B | -2.02% | 27.54 | 38.44% |
Healthpeak Properties, Inc. | Buy | $15.6B | 17.6% | 45.4 | 12.11% |
Ventas, Inc. | Buy | $27.0B | 10.06% | 2223.5 | -1.39% |
Welltower Inc. | Buy | $84.7B | 61.44% | 86.6 | 12.12% |
Omega Healthcare Investors Inc. | Hold | $11.4B | -4.05% | 30.13 | 34.41% |
Insights on National Health Investors Inc.
Revenue is down for the last 2 quarters, 85.69M → 69.17M (in $), with an average decrease of 19.3% per quarter
Netprofit is down for the last 2 quarters, 35.25M → 28.54M (in $), with an average decrease of 19.1% per quarter
In the last 1 year, Healthpeak Properties, Inc. has given 83.8% return, outperforming this stock by 38.3%
Vanguard Group Inc
BlackRock Inc
State Street Corp
Principal Financial Group Inc
Macquarie Group Ltd
Geode Capital Management, LLC
In the quarter ending March,2024. National Health Investors Inc. has declared dividend of $0.90
Read Moreincorporated in 1991, national health investors, inc. (nyse: nhi) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. nhi’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. for more information, visit www.nhireit.com.
Organization | National Health Investors Inc. |
Employees | 26 |
CEO | Mr. D. Eric Mendelsohn |
Industry | Finance |